Searched for
EVER GREENING OF PATENTS
Non-violation complaints under WTO's TRIPS agreement: An explainerWorld Trade Organisation members could not agree to extend a safeguard on intellectual property rules. This means the moratorium on non-vio...- India will not allow evergreening of patents: Piyush GoyalCommerce and Industry Minister Piyush Goyal affirmed India's commitment to preventing the "evergreening" of patents, despite having robust ...
- Indian pharma firms not copying products, India respect IP rights, says GoyalCommerce and Industry Minister Piyush Goyal refuted claims that Indian pharmaceutical firms copy Swiss products, calling it a long-standing...
- US keeps India on intellectual property priority watch listOn the other hand, India has always maintained that its IPR regime is in compliance with the global rules including that of the World Trade...
- Proposals undermining innovators won't help India: US Chambers of CommerceIndia and the US had seemingly found a common ground at the Trade Policy Forum on aspects of trade secrets protection, copyright enforcemen...
- Cipla asks government to revoke five patents held by NovartisCipla, India’s fifthlargest drugmaker by revenue, has asked the government to revoke five patents that Novartis holds on respiratory drug O...
- India says US Special 301 process on IPR is a unilateral measureOn April 30, the US has brought out the Special 301 report, an annual review of the global state of IPR protection and enforcement.
- Amazon gets patent for ‘photos against a white background’Amazon has officially been granted a patent for its brilliant idea to take photos on a white background by US Patent and Trademark Office.
- Ever-greening of patents cannot be permitted: DIPPIn a major blow to Swiss pharma giant Novartis, the SC earlier this month had rejected its plea for a patent on cancer drug Glivec.
- EU, Australia, Canada may follow India’s Patent LawIndia’s strong stance on minor drug innovations could reverberate in national parliaments and courthouses of the developed world.
- Novartis verdict is a victory for patients: YK Hamied, CiplaFor patenting of frivolous patents, unjustified patents, India is taking a very-very strong stand on that issue which will only help patien...
- Govt cautions pharma industry against harassment by global playersThe government on Tuesday cautioned the domestic pharmaceutical industry against attempts by global giants to "harass" them through their "...
- MNC, domestic pharma cos lock horns over patents in IndiaMNC durgmakers on Wednesday hit back at their domestic counterparts over frivolous patent issue and said even the local firms are engaged i...
- Dichotomy between patent law and practiceIndia's Patents Act is globally appreciated, but the authorities here are flouting it themselves.
- Verdict in line with report: MashelkarRA Mashelkar, who chaired the panel that recommended that incremental developments be encouraged by the Indian patent regime, says acceptan...
- Norway asks Novartis to withdraw caseSwedish government backs India in patent fight against pharma-major Novartis.
- Govt opposed to ever-greening of patentsThe controversial Mashelkar Committee report, which said India will violate WTO agreements if it restricts patents only to new chemical ent...
- Mashelkar may’veto stick to doseThe government is unlikely to give the Technical Expert Group on patent law - headed by former CSIR DG RA Mashelkar - more time to re-visit...
- Will Mashelkar's proposal spoil pharma cos' generics dream run?The fight between India’s globally competent generic drugmakers and the R&D-intensive Big Pharma in the West, who are being increasingly ch...
- Leg-up for MNC pharma cos as panel faults patents lawA high-level panel headed by Council of Scientific and Industrial Research (CSIR) director-general RA Mashelkar has told the government tha...
Load More
